Ultragenyx Pharmaceutical (RARE) Treasury Shares (2014 - 2026)

Ultragenyx Pharmaceutical (RARE) has 4 years of Treasury Shares data on file, last reported at $10.0 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $10.0 million, up 32.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 million (up 32.17% YoY), and the FY2025 annual result was $8.0 million, up 100.0% from the prior year.
• Treasury Shares improved to $10.0 million in Q1 2026 per RARE's latest filing, from $8.0 million in the prior quarter.
• Over five years, Treasury Shares peaked at $300000.0 in Q1 2026 and troughed at $7812.0 in Q1 2023.
• A 4-year average of $103094.8 and a median of $68923.0 in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2024 and 2026: Treasury Shares soared 835.96% in 2024, then jumped 32.17% in 2026.
• A 4-year view of Treasury Shares shows it stood at $432000.0 in 2023, then surged by 825.93% to $4.0 million in 2024, then jumped by 100.0% to $8.0 million in 2025, then advanced by 25.0% to $10.0 million in 2026.
• Business Quant data shows RARE's Treasury Shares at $10.0 million in Q1 2026, $8.0 million in Q4 2025, and $8.0 million in Q3 2025.